A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model

Overview of attention for article published in BMC Infectious Diseases, December 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 12 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Meningococcal disease serogroup B. Updated information for the Dutch Health Council

Cited by Rijksinstituut voor Volksgezondheid en Milieu on 11 Apr 2022

RIVM works to prevent and control outbreaks of infectious diseases. We promote public health and consumer safety, and we help to protect the quality of the environment.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.